Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India
The company will work with new local contract manufacturers in India to boost supply of its key medicines.
FDA launches generics pilot program, advances facility PreCheck proposal in bid to incentivize US drug manufacturing
The FDA unveiled a new pilot program that aims to speed up review times for generic drugmakers who test and manufacture their products in the U.S. Separately, the agency met with industry
Cidara snares up to $339M from BARDA to bankroll its non-vaccine flu candidate
The initial part of the up-to-$339 million funding will largely be used to establish U.S. manufacturing for the non-vaccine flu preventive candidate, with additional options tied to further clinical studies, Cidara said.
Vaxcyte strikes up to $1B deal for fill-finish space at Thermo Fisher’s N.C. production facility
Vaxcyte is paying Thermo Fisher Scientific up to $1 billion to access vaccine fill-finish capacity at the CDMO’s production facility in Greenville, North Carolina. Vaxcyte positioned the deal as a “long-term U.S.
Ansa snares $54.4M in series B financing to boost its DNA synthesis platform
Ansa Biotechnologies hauled in a total of $54.4 million in an oversubscribed series B financing round that will be used to expand the company’s DNA synthesis production capacity in the U.S.